daiichi-sankyo-s-comments-enrages-the-singh-family-the-former-shareholder-and-owners-of-ranbaxy

Daiichi's comments upset former Ranbaxy owners

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Japanese drugmaker Daiichi Sankyo, which currently holds a majority stake in Ranbaxy, had earlier highlighted that it believes that former shareholders... Read more

us-fda-panel-s-opinion-was-somewhat-at-odds-with-the-agency-s-own-scientists-who-issued-a-negative-review-of-the-merck-drug

FDA votes +ve for Merck drug despite glitches in trial data...

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: An US FDA panel has voted that Merck & Co experimental insomnia drug appears to be safe and effective, despite evidence from company trials that the pill... Read more

good-to-go-3sbio-shareholders-are-in-favor-of-plan-of-merger

3SBio shareholders get nod for merger agreement

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The shareholders of China-based 3SBio have voted at an extraordinary general meeting (EGM) in favor of a proposal to authorize and approve the previously... Read more

macrocyclics-to-collaborate-with-roche-on-molecular-innovation-for-nuclear-medicine

Macrocyclics to design chelating agents for Roche

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Macrocyclics, an Areva Med company, entered into a new collaborative research agreement with Roche for the continued development of novel chelating agents... Read more

johnson-johnson-launched-11-new-products-since-2009-which-have-raked-in-17-percent-of-its-total-pharma-sales-last-year

J&J to seek nod for 11 new drugs by 2017

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Johnson & Johnson (J&J) revealed that it is aiming to apply for approval of 10 new drugs in the US and Europe, a polio vaccine for other parts of the... Read more

one-third-of-ranbaxy-s-14-600-global-sales-staff-may-lose-their-jobs

Ranbaxy may fire 1/3rd of its global sales staff

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Ranbaxy Laboratories is contemplating on slashing its global sales staff by about a third, with a majority of the job cuts expected to be in the US, according... Read more

daiichi-may-take-legal-action-against-former-shareholders-of-ranbaxy-as-it-believes-that-they-concealed-and-misrepresented-critical-information-concerning-the-us-department-of-justice-doj-and-us-fda-inves

Daiichi may take legal action against ex-Ranbaxy promoters...

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Breaking its silence for the first time in 10 days after Indian drug major Ranbaxy's $500 million settlement of the US Food and Drug Administration (FDA)... Read more

respiratory-and-acute-care-product-group-rac-operating-revenue-grew-18-percent-and-obstructive-sleep-apnea-product-group-osa-operating-revenue-grew-10-percent

Fisher & Paykel records profit of $62.40 mn

  • New Zealand
  • |
  • Company Results
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Fisher & Paykel Healthcare reported record net profit after tax of $62.40 million (NZ$77.1 million) for the year ended March 31, 2013, an increase of... Read more

agilent-openlab-data-store-for-ms-is-compliant-with-agilent-s-icp-ms-masshunter-system

Agilent launches software for mass spectral data storage...

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Agilent Technologies launched ‘OpenLAB Data Store for MS', a simple and affordable networked solution for compliant storage of mass spectral data acquired... Read more

ranbaxy-reflects-on-the-its-actions-that-it-been-taking-in-recent-years-to-ensure-the-safety-and-efficacy-of-all-its-products

Ranbaxy reflects on steps taken for product safety

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Ranbaxy Laboratories highlighted some of the major specific actions the company has been taking in recent years to address certain conduct of the past... Read more

axway-will-help-sanofi-ensure-that-all-divisions-subsidiaries-and-new-acquisitions-are-able-to-efficiently-and-securely-exchange-and-manage-data-in-a-way-that-is-uniform-globally

Axway helps Sanofi to ‘fool-proof’ its IT infrastructure...

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Sanofi joined hands with Axway in order to streamline processes and transform its technology infrastructure into an efficient global network. Axway will... Read more

mayo-clinic-and-cancer-genetics-form-joint-venture-oncospire-genomics-with-an-aim-to-improve-cancer-care

Mayo Clinic, Cancer Genetics form OncoSpire JV

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Mayo Clinic and Cancer Genetics have collaborated to form OncoSpire Genomics, a 50:50 joint venture (JV) with the singular goal of improving cancer care... Read more

ims-health-acquired-360-vantage-a-leading-provider-of-cloud-based-multi-channel-customer-relationship-management-crm-and-closed-loop-marketing-technologies

IMS Health acquires 360 Vantage

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: IMS Health has acquired 360 Vantage, a leading provider of cloud-based multi-channel customer relationship management (CRM) and closed loop marketing... Read more

nanoparticles-developed-using-natural-lipids-from-grapefruit-named-grapefruit-derived-nanovectors-can-be-used-to-delivery-cancer-drugs-to-cells

Grapefruit nanoparticles can deliver cancer drug

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A study conducted at the University of Louisville, US, has found out the way to create nanoparticles using natural lipids derived from grapefruit, and... Read more

more-reasons-to-eat-citrus-fruits-vitamin-c-triggers-reactive-oxygen-production-to-kill-drug-resistant-tuberculosis-tb

Einstein College study: Vitamin C kills drug-resistant TB...

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Researchers at the Yeshiva University, US, have discovered that vitamin C triggers the production of reactive oxygen species called free radicals, which... Read more

Previous 1 3 4 5 6 7

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X